A multicenter. open-label study of the safety of intravenous sodium valproate in 318 hospitalized patients with epilepsy is reported from the NYU Hospital for Joint Diseases; MINCEP Epilepsy Care and Minnesota Epilepsy Group, MN; University of Texas, Houston; Medical College of Virginia, Richmond; Bowman-Gray School of Medicine, Winston-Salem, NC; and University of Miami, FL.

Millichap, J.G., 0AD. Safety of Intravenous Valproate. Pediatric Neurology Briefs, {volume}({issue}), p.{page}.DOI: https://doi.org/10.15844/pedneurbriefs-9-12-3

Millichap, J G. “Safety of Intravenous Valproate”. Pediatric Neurology Briefs, vol. {volume}, no. {issue}, 0AD, p. {page}.DOI: https://doi.org/10.15844/pedneurbriefs-9-12-3

Millichap, J. G. (0AD). Safety of Intravenous Valproate. Pediatric Neurology Briefs, {volume}({issue}), {page}.DOI: https://doi.org/10.15844/pedneurbriefs-9-12-3

Millichap, J Gordon. 0AD. “Safety of Intravenous Valproate”. Pediatric Neurology Briefs {volume} ({issue}): {page}.DOI: https://doi.org/10.15844/pedneurbriefs-9-12-3

1. Millichap JG. Safety of Intravenous Valproate. Pediatric Neurology Briefs. 0AD;{volume}({issue}):{page}. DOI: https://doi.org/10.15844/pedneurbriefs-9-12-3

1. Millichap JG. Safety of Intravenous Valproate. Pediatric Neurology Briefs. 0AD;{volume}({issue}):{page}.DOI: https://doi.org/10.15844/pedneurbriefs-9-12-3

Millichap JG, ‘Safety of Intravenous Valproate’ (0AD) {volume} Pediatric Neurology Briefs {page}DOI: https://doi.org/10.15844/pedneurbriefs-9-12-3

[1]J. G. Millichap, “Safety of Intravenous Valproate”, Pediatric Neurology Briefs, vol. {volume}, no. {issue}, p. {page}, 0AD.DOI: https://doi.org/10.15844/pedneurbriefs-9-12-3

This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 license (unless stated otherwise) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Antiepileptic Medications

Safety of Intravenous Valproate

Authors:

Abstract

Keywords: